Drug Recalls – January 17, 2020

Drug Recalls - January 17, 2020

(UnitedVoice.com) – Our medications should keep us healthy, not harm us. That’s why it’s important to stay up-to-date on prescription drug recalls. Here are some recent recalls from major drug manufacturers.

Ranitidine (01/10/2020)

Popular heartburn drug Ranitidine has been involved with recalls since November. Now another manufacturer has recalled the medicine because of possible carcinogenic impurities.

Denton Pharma, Inc. dba Northwind Pharmaceuticals, has issued a voluntary recall of all 150mg and 300 mg Ranitidine tablets. The recall is part of a larger one because of the presence or potential presence of NDMA.

TEST

NDMA is a chemical that can form naturally during industrial processes. It’s known to cause cancer when present in higher than recommended levels.

Lamotrigine (01/11/2020)

Taro Pharmaceutical Industries has issued a recall of the epilepsy and bipolar medication Lamotrigine. The recall is due to the presence of Enalapril Maleate, a heart and blood pressure medication, which was caused by cross-contamination.

The only dose included in the recall right now is Lamotrigine 100mg, lot No. 331771, with an expiration date of June 2021.

TEST

Remeron (01/03/2020)

Aurobindo Pharma has recalled depression medicine Mirtazapine, sold under the brand name of Remeron because some bottles might have the wrong pills.

It was discovered that bottles labeled as 7.5 mg might actually contain 15 mg tablets. The official recall states that “Taking a higher dose than expected may increase risk of sedation, agitation, increased reflexes, tremor, sweating, dilated pupils, gastrointestinal distress, nausea, constipation and more.”

The pills involved in the recall are from lot number 03119002A3 with an expiration date of 03/2022.

TEST

Consumers who have questions are being asked to call Aurobindo Pharma at 1-566-850-2876 and choose option 2.

Copyright 2020, UnitedVoice.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here